Delcath Systems Publishes FOCUS Study Analysis on Uveal Melanoma
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a...
Category : Healthcare and Pharmaceutical
Kensington Private Hospital Sets New Standard with Provation MD
Kensington Private Hospital has implemented Provation® MD, a market-leading GI procedure documentation solution. This transition marks a significant step forward in enhancing operational efficiencies, reporting accuracy,...
Avanzanite Appoints Sotiris Botozis as GM of Southern Europe
Avanzanite Bioscience B.V. proudly announces the appointment of Sotiris Botozis as General Manager Southern Europe. As the fourth executive leadership hire of 2025, this move...
Cepheid & Oxford Nanopore Partner to Advance Sequencing Solutions
Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases Oxford Nanopore Technologies, the company behind...
EvolveImmune, MSK Partner on Bladder Cancer Target Study
EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced a translational research collaboration...
65% of Top 100 US Hospitals Hit by Recent Data Breach
In 2024, healthcare data breaches reached an all-time high, with 276,775,457 records compromised – a 64.1% increase from the previous year’s record and equivalent to 81.38% of...
Angelini Ventures Names Dr. Regina Hodits Managing Director
Accomplished biotech investor with a track record of successful company-building and exits to lead Angelini Ventures’ international BioTech investment strategy Angelini Ventures, the corporate venture...
Noom Appoints Dr. Jeffrey Egler as Chief Medical Officer
Dr. Egler brings extensive experience in functional medicine leadership to Noom as it expands its services to meet consumer health demands across a wider range...
Remegen Announces Phase 3 Trial Results of Telitacicept for gMG
On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in...
ZRG Adds Joni Noel as Co-Head of Healthcare & Life Sciences
ZRG, the world’s fastest-growing full-service talent advisory firm, today announced the appointment of Joni Noel as Co-Head of its Healthcare & Life Sciences Practice. Joni will...
Infinitopes Gets Approval for Trial of Precision Cancer Vaccine
Infinitopes Ltd today announces that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase...
Newleos Therapeutics Expands Team to Advance CNS Programs
Seasoned clinical and medical experts join to propel potential first- and best-in-class programs in anxiety, substance use disorders and cognitive impairment Strategic corporate appointments enhance...
Rondo Therapeutics Publishes Preclinical Data on RNDO-564 Therapy
RNDO-564 is designed to deliver safe and robust tumor killing activity in Nectin-4 positive tumors. RNDO-564 utilizes a novel mechanism of action for the treatment...
AI Proteins CEO to Speak at TED on Miniprotein Therapeutics
AI Proteins, a Boston-based biotech company pioneering the design of novel miniprotein therapeutics, today announced that its President, CEO, and Founder, Chris Bahl, will be...
Leyden Labs Shares New Data on Intranasal Antibody Potential
Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced the publication of new findings that showcase the advantages of intranasal administration of monoclonal antibodies...